Among more than 50 deals that occurred last year involving Oregon and southwest Washington companies or assets, the Business Journal found just 20 in which terms were disclosed last year. These amounted to $25.3 billion in cash, stock and debt transaction, little more than half of the haul in 2015, but a 334% increase over the value of disclosed deals in 2020. This compares to just a 34% increase in deal value across the U.S. — from $1.1 trillion in 2020 to $1.5 trillion in 2021 — according to Capital IQ data gathered by the Institute for Mergers, Acquisitions and Alliances.
Over the last few years, I’ve been lucky to work with founders and management teams to sell about $5b of startups. During that time, I’ve observed a few things about M&A. Here are 10 of my learnings…
Patrick Gelsinger is back running a company he first joined at 18. The chip maker was a Silicon Valley titan that lost its luster. As the world craves chips, the C.E.O. has faith he can fix it all.
Daily recently restructured our levels, promotions and salaries in somewhat unusual ways, and we want to share what we’re doing. We’re still early enough in our growth that we can’t compete with companies like Google and Netflix on salary alone. But we can be thoughtful in how we approach careers and compensation.
Lytics, a leading customer data platform (CDP) that improves business outcomes using first-party data, today announces that its Lytics Cloud Connect product is now available through the Microsoft Azure Marketplace. Lytics is the first, and only, reverse ETL offering available in the Azure Marketplace and users of Cloud Connect can connect from Azure to one destination for free with the option to upgrade for more destinations.
AOBIO kicks off February 23rd with a four-week investment-readiness education series for life and bioscience startups at any stage of development. The program will feature local founders who have scaled successful companies in therapeutics, diagnostics, medical devices, or health innovation.AOBIO kicks off February 23rd with a four-week investment-readiness education series for life and bioscience startups at any stage of development. The program will feature local founders who have scaled successful companies in therapeutics, diagnostics, medical devices, or health innovation.